These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2226115)

  • 21. 13th Alexander Brown memorial lecture given on 22 February 1985 by G. Onuaguluchi. "Cardiotonic Drugs in the Management of Chronic Congestive Heart Failure: Digitalis Revisited ".
    Oruaguluchi G
    Afr J Med Med Sci; 1989 Dec; 18(4):315-28. PubMed ID: 2558565
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
    Uretsky BF; Lawless CE; Verbalis JG; Valdes AM; Kolesar JA; Reddy PS
    Chest; 1987 Oct; 92(4):657-62. PubMed ID: 3308346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute haemodynamic effects of intravenous amrinone in chronic congestive heart failure.
    Bahl VK; Khalilullah M
    Indian Heart J; 1984; 36(6):369-74. PubMed ID: 6535755
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure.
    Levinoff Roth SN; Moe G
    Can J Cardiol; 1993 Apr; 9(3):231-7. PubMed ID: 8508332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term survival of class IV heart failure patients treated with oral amrinone.
    Moran JF; Rad N; Scanlon PJ
    J Clin Pharmacol; 1989 Jun; 29(6):494-9. PubMed ID: 2754019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB; Rutledge DR; Pieper JA
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of amrinone on patients with moderate and severe cardiac dysfunction after open heart surgery].
    Kunimoto F; Arai K; Isa Y; Satoh Y; Fujita T; Koyano T; Nagasawa S; Ohbayashi T; Kaneko T
    Masui; 1995 Jan; 44(1):42-50. PubMed ID: 7699823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology.
    Wilson H; Rocci ML; Weber KT; Andrews V; Likoff MJ
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):3-19. PubMed ID: 3589153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute pharmacokinetics and pharmacodynamics of amrinone in pediatric patients.
    Lawless ST; Zaritsky A; Miles M
    J Clin Pharmacol; 1991 Sep; 31(9):800-3. PubMed ID: 1804862
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemodynamic effects of amrinone in children after cardiac surgery.
    Berner M; Jaccard C; Oberhansli I; Rouge JC; Friedli B
    Intensive Care Med; 1990; 16(2):85-8. PubMed ID: 2332544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of positive inotropic response to acute amrinone administration in chronic cardiac failure.
    Scognamiglio R; Fasoli G; Visintin L; Maragno I; Cargnelli G; Piovan D; Dalla-Volta S
    Eur Heart J; 1986 Jul; 7(7):621-7. PubMed ID: 3758094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
    Kanda M; Yasuda S; Goto Y; Sumida H; Baba T; Noguchi T; Nonogi H
    Am J Cardiol; 1999 Apr; 83(8):1274-7, A9. PubMed ID: 10215299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New inotropic agents in the treatment of refractory congestive heart failure].
    Hertzeanu H; Pines A
    Harefuah; 1988 Mar; 114(6):290-3. PubMed ID: 3286406
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of intravenous amrinone in the treatment of cardiogenic shock].
    Bichel T; Steinbach G; Olry L; Lambert H
    Agressologie; 1988 Mar; 29(3):187-92. PubMed ID: 3213857
    [No Abstract]   [Full Text] [Related]  

  • 36. Amrinone therapy for severe pulmonary hypertension and biventricular failure after complicated valvular heart surgery.
    Cheng DC; Asokumar B; Nakagawa T
    Chest; 1993 Nov; 104(5):1618-20. PubMed ID: 8222841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ; Lvoff R; Chong B; Barrett PA
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of amrinone in refractory cardiac insufficiency: clinical and hemodynamic evaluation].
    Massari FM; De Martini M; Foresti A; Valentini R; Bertoni T; Lotto A
    G Ital Cardiol; 1986 Oct; 16(10):845-54. PubMed ID: 3817367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amrinone.
    Wilmshurst P
    Am J Cardiol; 1987 Oct; 60(10):940-1. PubMed ID: 3661419
    [No Abstract]   [Full Text] [Related]  

  • 40. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
    Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
    Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.